Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05324098 · ClinicalTrials.gov registry record · NA

Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy

A NA study of Prostate Cancer, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
47
Enrollment target
2
Study locations

NCT05324098 is a NA study of Prostate Cancer that has completed, run by University of California, San Francisco. The registered enrollment target is 47 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05324098, a NA study of Prostate Cancer, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
47 participants
Enrollment target
2
Study locations

Study Summary

This clinical trial studies a digital platform, the supportive therapy in androgen deprivation (STAND-T), in achieving equity for men undergoing treatment with androgen deprivation therapy for prostate cancer. STAND-T is a digital platform that provides prostate health information, evidence-based materials and resources. STAND-T may help improve health, address symptoms, and promote equity in men with prostate cancer.

Conditions Studied

Prostate Cancer

Interventions

  • OTHER Survey Administration
  • OTHER STAND-T platform
  • OTHER Text Messages

Study Locations (2)

California

  • Zuckerberg San Francisco General Hospital - San Francisco
  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2022-03-08
Est. Completion 2023-07-31
Phase NA

Sponsor

University of California, San Francisco

1,713 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05324098

The ClinicalTrials.gov registry entry for NCT05324098 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.

NCT05324098 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05324098 about?

NCT05324098 is a clinical study titled "Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy". This clinical trial studies a digital platform, the supportive therapy in androgen deprivation (STAND-T), in achieving equity for men undergoing treatment with androgen deprivation therapy for prostate cancer. STAND-T is a digital platform that provides prostate health information, evidence-based ma...

What is the current status of trial NCT05324098?

This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2022-03-08. Estimated completion is 2023-07-31.

What conditions does trial NCT05324098 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT05324098?

The interventions under investigation include: Survey Administration (OTHER), STAND-T platform (OTHER), Text Messages (OTHER).

Who is sponsoring clinical trial NCT05324098?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05324098 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.